Previous Article | Next Article ![]()
Journal of Virology, December 1999, p. 10346-10358, Vol. 73, No. 12
Department of Pathology and Laboratory
Medicine, University of Pennsylvania, Philadelphia, Pennsylvania
19104
Received 22 June 1999/Accepted 8 August 1999
Binding of the extracellular subunit of human immunodeficiency type
1 (HIV-1) envelope (Env) glycoprotein (gp120) to CD4 triggers the
induction or exposure of a highly conserved coreceptor binding site in
gp120 that helps mediate membrane fusion. Characterizing the structural
features involved in gp120-coreceptor binding and the conditions under
which binding occurs is important for understanding the fusion process,
the evolution of pathogenic strains in vivo, the identification of
novel anti-HIV compounds, and the development of HIV vaccines that
utilize triggered structures of Env. Here we use the kinetics of
interaction between CCR5 and gp120 to understand temporal and
structural changes that occur during viral fusion. Using saturation
binding and homologous competition analysis, we estimated the
Kd of interaction between CCR5 and gp120 from the macrophage tropic HIV-1 strain JRFL to be 4 nM. Unlike Env-mediated fusion, gp120 binding to CCR5 did not require divalent cations or
elevated temperatures. Binding was not significantly affected by the pH
of binding, G-protein coupling of CCR5, or partial gp120 deglycosylation. Oligomeric, uncleaved JRFL gp140 failed to bind CCR5
despite its ability to bind CD4 and monoclonal antibody 17b, suggesting
that the uncleaved ectodomain of gp41 interferes with full exposure of
the chemokine receptor binding site. Exposure of the chemokine receptor
binding site on gp120 could be induced rapidly by CD4, but exposure of
this site was lost upon CD4 dissociation from gp120, indicating that
the conformational changes in gp120 induced by CD4 binding are fully
reversible. The functional gp120-soluble CD4 complex was remarkably
stable over time and temperature ranges, offering the possibility that
complexes in which the highly conserved coreceptor binding site in
gp120 is exposed can be used for vaccine development.
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Use of a gp120 Binding Assay To Dissect the
Requirements and Kinetics of Human Immunodeficiency Virus Fusion
Events
*
Corresponding author. Mailing address for Benjamin J. Doranz: University of Pennsylvania, Department of Pathology & Laboratory Medicine, 806 Abramson, 34th and Civic Center Blvd.,
Philadelphia, PA 19104. Phone: (215) 898-0891. Fax: (215) 573-2883. E-mail: doranz{at}mail.med.upenn.edu. Mailing address for
Robert W. Doms: University of Pennsylvania, Department of Pathology & Laboratory Medicine, 807 Abramson, 34th and Civic Center Blvd.,
Philadelphia, PA 19104. Phone: (215) 898-0890. Fax: (215) 573-2883. E-mail: doms{at}mail.med.upenn.edu.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|